Which of the following is an example of a neutralization reaction?
Haptens are immunogenic when they covalently bind to which type of carrier?
To which part of an antigen do monoclonal antibodies specifically bind?
What is required for precipitation in comparison to agglutination?
Which of the following does not stimulate active immunity?
What type of immunity is primarily associated with the administration of transfer factor?
Phagocytosis of mycobacterium tuberculosis by macrophages is mainly mediated by:
CD3 is a marker for which type of cells?
Which type of DNase produced by Streptococcus is known to be the most antigenic in humans?
Lattice phenomenon is seen in which of the following?
Explanation: ***Nagler reaction*** - The Nagler reaction is a **neutralization test** used to detect α-toxin (lecithinase) produced by *Clostridium perfringens*. - A positive result occurs when Lecithinase activity is **neutralized by antitoxin**, preventing hydrolysis of lecithin in egg yolk agar. *VDRL* - The **Venereal Disease Research Laboratory (VDRL) test** is a flocculation test used for screening syphilis, detecting cardiolipin antibodies. - It involves the clumping of **antigen-antibody complexes**, not the neutralization of a toxin. *Widal test* - The **Widal test** is an agglutination test for the diagnosis of enteric fever (typhoid), detecting antibodies against *Salmonella* O and H antigens. - It identifies bacterial agglutination, which is the **clumping of bacterial cells** in the presence of specific antibodies. *Kahn test* - The **Kahn test** is another flocculation test, similar to VDRL, historically used for syphilis screening. - It involves the precipitation of a lipid antigen by syphilitic antibodies, which is an **agglutination phenomenon**, not neutralization.
Explanation: ***Protein carrier*** - Haptens are small molecules that are **antigenic** but not **immunogenic** on their own; they acquire immunogenicity when covalently bound to a larger carrier molecule. - **Proteins** are highly effective carriers because their complex structures and multiple epitopes can induce strong T-cell help, which is crucial for a robust antibody response against the hapten. *Lipid carrier* - While some lipids can be antigenic (e.g., glycolipids), they generally do not serve as effective carriers for haptens to induce a strong adaptive immune response, especially T-cell-dependent responses. - **Lipids** are less likely to be processed and presented by MHC molecules in a way that generates potent helper T-cell activation. *Polysaccharide carrier* - Some polysaccharides can be immunogenic themselves (e.g., bacterial capsular polysaccharides) and can induce T-cell-independent antibody responses. - However, for haptens to become immunogenic and induce a **T-cell-dependent antibody response**, a protein carrier is typically required. *None of the above carrier* - This option is incorrect because haptens do require a carrier to become immunogenic, and specific types of carriers are more effective than others. - The type of carrier chosen significantly impacts the **strength and nature of the immune response** to the hapten.
Explanation: ***Specific epitope on the antigen*** - Monoclonal antibodies are designed to recognize and bind to a **unique, specific region** on an antigen, known as an **epitope**. - This high specificity is crucial for their clinical applications, such as targeted therapies and diagnostic tests. *Both the epitope and the paratope* - The **epitope** is the part of the antigen, while the **paratope** is the part of the antibody that binds to the epitope. - An antibody binds to an epitope, not to both itself and its own binding site. *None of the options* - This option is incorrect because there is a correct answer among the choices provided, which accurately describes the binding site of monoclonal antibodies. *Part of the antibody that binds to the epitope* - This describes the **paratope**, which is the antigen-binding site on the antibody, not the part of the antigen to which the antibody binds. - The question specifically asks about the part of the antigen.
Explanation: ***Soluble antigen*** - **Precipitation reactions** involve the interaction of antibodies with **soluble antigens** to form a detectable precipitate. - Unlike **agglutination**, which involves particulate antigens (e.g., cells), precipitation requires the antigen to be dissolved in a solution. *Increased temperature* - Most immunologic reactions, including precipitation and agglutination, are typically performed at **physiological temperatures** (e.g., 37°C) or room temperature. - An **increased temperature** is not a specific requirement that differentiates precipitation from agglutination. *Specific cofactor* - While some complex immunologic reactions might require **cofactors**, neither precipitation nor agglutination inherently requires a specific cofactor to occur. - The primary components are **antigen** and **antibody**. *Lower pH* - Both precipitation and agglutination reactions are sensitive to pH and typically occur within a **narrow pH range** close to neutral (e.g., pH 7.0-7.4). - A **lower pH** (acidic environment) could lead to antibody denaturation or non-specific aggregation, ultimately hindering the reaction rather than being a requirement.
Explanation: ***Transplacental antibody transfer in newborn*** - This is a form of **passive immunity**, where pre-formed **antibodies from the mother** are transferred to the newborn, providing immediate but temporary protection. - It does not involve the newborn's own immune system generating an immune response or creating **memory cells**. *Subclinical infection* - Even without overt symptoms, a **natural infection** exposes the immune system to pathogens, triggering an active immune response and generating **memory cells**. - This leads to **long-term immunity** against future exposures to the same pathogen. *Clinical infection* - A **symptomatic natural infection** involves the immune system actively responding to the pathogen, producing antibodies and **memory cells**. - This process is the basis of **naturally acquired active immunity** and provides durable protection. *Vaccination* - Vaccines contain weakened or inactive forms of pathogens, or their components, which stimulate the immune system to produce **antibodies** and **memory cells** without causing disease. - This is an example of **artificially acquired active immunity**, providing long-lasting protection.
Explanation: ***Adoptive immunity (Correct)*** - **Transfer factor** consists of small, dialyzable molecules extracted from immune T lymphocytes of an immune donor - Its administration transfers **cell-mediated immunity** from donor to recipient, which defines adoptive immunity - This represents transfer of **immune cells or their products** (not antibodies), providing antigen-specific cellular immunity - Also called **adoptive immunotherapy** or adoptive transfer *Artificial passive immunity (Incorrect)* - Involves the **transfer of pre-formed antibodies** (e.g., antitoxins, immunoglobulins, antiserum) from an immune individual or animal - Provides **immediate but temporary humoral protection** - Does NOT transfer cellular immunity - this is the key distinction from adoptive immunity - Examples: Anti-rabies immunoglobulin, anti-tetanus serum *Natural active immunity (Incorrect)* - Occurs when an individual is **naturally exposed to an antigen** (infection) and produces their own antibodies and immune cells - The host's own immune system **actively responds** to develop long-lasting immunity - Example: Immunity after recovering from measles or chickenpox *Artificial active immunity (Incorrect)* - Achieved through **vaccination** with attenuated, inactivated, or subunit antigens - The recipient's body is **actively stimulated** to produce protective immunity - Provides long-lasting protection through immunological memory
Explanation: ***Interferon Gamma*** - **Interferon gamma (IFN-γ)** is the most critical cytokine for **macrophage activation** in tuberculosis, enabling effective phagocytosis and intracellular killing of **Mycobacterium tuberculosis**. - IFN-γ (produced by **Th1 cells** and **NK cells**) primes macrophages by: - Enhancing **phagosome-lysosome fusion** - Increasing expression of **Fc receptors** and **complement receptors** for better opsonization - Stimulating production of **reactive oxygen species (ROS)** and **nitric oxide (NO)** - Upregulating **MHC class II** for improved antigen presentation - Without IFN-γ, macrophages cannot effectively control intracellular mycobacterial growth (as seen in **IFN-γ or IL-12 receptor deficiencies** leading to disseminated mycobacterial infections). *Interleukin 6* - **IL-6** is a pro-inflammatory cytokine involved in **acute-phase responses**, fever induction, and B-cell differentiation. - While it contributes to systemic inflammatory responses in TB, it does not directly activate macrophages for mycobacterial phagocytosis and killing. *Interleukin 3* - **IL-3** is a **hematopoietic growth factor** that promotes proliferation and differentiation of myeloid and lymphoid progenitor cells in bone marrow. - It plays no direct role in the effector functions of mature macrophages against *M. tuberculosis*. *Interleukin 12* - **IL-12** (produced by macrophages and dendritic cells) is essential for initiating **Th1 immunity** by promoting differentiation of naive CD4+ T cells into **Th1 cells** that produce IFN-γ. - IL-12 acts **upstream** of IFN-γ in the immune cascade but does not directly mediate macrophage phagocytic function. - The **IL-12/IFN-γ axis** is critical for TB immunity, but IFN-γ is the direct macrophage activator.
Explanation: ***T - cells*** - **CD3** is a complex of proteins that is universally expressed on the surface of all **T lymphocytes** (T cells). - It plays a crucial role in **T cell activation** by transducing signals from the T cell receptor (TCR) to the cell's interior. *B - cells* - **B cells** are characterized by the expression of unique surface markers like **CD19**, **CD20**, and surface **immunoglobulins**, not CD3. - Their primary function is to produce **antibodies** and present antigens. *NK - cells* - **Natural Killer (NK) cells** are a type of lymphocyte that lacks both CD3 and a T cell receptor (TCR), differentiating them from T cells. - They express markers such as **CD16** and **CD56** and are involved in innate immunity, particularly against viral infections and tumor cells. *Monocytes* - **Monocytes** are myeloid cells, not lymphocytes, and are characterized by markers such as **CD14** and **CD68**. - They differentiate into macrophages and dendritic cells, playing a significant role in phagocytosis and antigen presentation.
Explanation: ***DNase B*** - **DNase B** is the most **antigenic** of the four DNases (A, B, C, D) produced by *Streptococcus pyogenes*. - Antibodies against DNase B are commonly measured as anti-DNase B titers in the diagnosis of **streptococcal infections** and their sequelae, like **acute rheumatic fever** and **post-streptococcal glomerulonephritis**, especially when ASO titers are negative. *DNase A* - While *Streptococcus pyogenes* produces **DNase A**, it is not considered the most antigenically potent or clinically relevant for antibody testing in humans. - Its antigenicity is generally **lower** than that of DNase B in response to streptococcal infection. *DNase C* - **DNase C** is another deoxyribonuclease produced by *Streptococcus pyogenes*. - Similar to DNase A, it does not elicit as strong or as consistent an **antibody response** in human infections compared to DNase B. *DNase D* - **DNase D** is the fourth type of deoxyribonuclease produced by *Streptococcus pyogenes*. - Its **antigenicity** in humans is less pronounced and less diagnostically significant than that of **DNase B**.
Explanation: ***Precipitation test*** - The **lattice phenomenon** describes the formation of an interconnected network of antigen-antibody complexes, which is essential for visible precipitation to occur. - This phenomenon dictates that optimal precipitation requires a specific **antigen-to-antibody ratio**; an excess of either can lead to false-negative results due to soluble immune complexes (prozone or postzone effects). *Complement fixation test* - This test relies on the **binding of complement** to antigen-antibody complexes, leading to the lysis of indicator red blood cells if complement is not fixed. - It is a **two-stage test** that measures the consumption of complement, not the direct observation of a lattice. *None of the options* - This option is incorrect because the **precipitation test** clearly demonstrates the lattice phenomenon. - The formation of a visible precipitate is a direct result of antigen-antibody lattice formation. *Neutralization reaction* - Neutralization involves antibodies binding to toxins or viruses, **blocking their biological activity** rather than forming a visible precipitate. - It is a **functional assay** that measures the ability of antibodies to inhibit harmful effects, not the formation of large immune complexes.
Cells and Organs of Immune System
Practice Questions
Innate Immunity
Practice Questions
Adaptive Immunity
Practice Questions
Antigens and Antibodies
Practice Questions
Major Histocompatibility Complex
Practice Questions
Complement System
Practice Questions
Cytokines and Chemokines
Practice Questions
Hypersensitivity Reactions
Practice Questions
Autoimmunity and Autoimmune Diseases
Practice Questions
Immunodeficiency Disorders
Practice Questions
Transplantation Immunology
Practice Questions
Tumor Immunology
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free